https://www.marketscreener.com/quote/stock/ROCHE-HOLDING-AG-9364975/news/Genentech-s-HEMLIBRA-emicizumab-kxwh-Significantly-Reduced-Bleeds-in-Phase-III-Study-in-Hemoph-25539126/?utm_source=telegram&utm_medium=social&utm_campaign=share